Dr. Jacqueline Shan is a noted Canadian entrepreneur and accomplished scientist with roots in the University of Alberta and Chinese Academy of Medical Sciences. In 2018, Dr. Shan founded PBG BioPharma, a licensed leader in the extraction, product formulation, and white-labelling of trusted, science-based, naturally-derived biopharmaceutical and consumer health products. The company is the first of its kind in Alberta to integrate a suite of testing and analytical labs and 25,000 square foot manufacturing facility under one roof to streamline the product development process.

Previously, Dr. Shan was co-founder, President, CEO and Chief Scientific Officer of Afexa Life Sciences Inc. (formerly CV Technologies Inc.), makers of the highly acclaimed and market-leading COLD-FX®.